A Feasibility Study to Evaluate Self-Harm Group in Inpatient Settings
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03035110|
Recruitment Status : Completed
First Posted : January 27, 2017
Last Update Posted : June 4, 2018
|Condition or disease||Intervention/treatment||Phase|
|Self-Injurious Behavior||Behavioral: Dialectical Behavioural Therapy (DBT) based skills groups||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||24 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Feasibility Study to Evaluate Self-Harm Group in Inpatient Settings|
|Actual Study Start Date :||April 18, 2017|
|Actual Primary Completion Date :||May 15, 2018|
|Actual Study Completion Date :||May 15, 2018|
Experimental: Dialectical Behavioural Therapy (DBT) skills group
Four group sessions, based on DBT, over two weeks, with a group of four to eight participants in attendance located on the hospital ward where the participant is a patient.
Behavioral: Dialectical Behavioural Therapy (DBT) based skills groups
Dialectical Behavioural Therapy (DBT) involves skills that help people manage their emotions and tolerate distress. This therapy is found effective in reducing self-harm behaviour for outpatients with Borderline Personality Disorder.
- The Inventory of Statements About Self-Injury (ISAS) [ Time Frame: 23 days ]ISAS is a self-report measure designed to assess the function and frequency of deliberate self-harm. It will be administered pre- and post-intervention.
- The Distress Tolerance Scale (DTS) [ Time Frame: 23 days ]The DTS consists of 15 items, which measure a person's appraisal of their emotional distress, their ability to tolerate this distress and any regulation efforts to alleviate it. It will be administered pre- and post-intervention.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03035110
|Ilford, Essex, United Kingdom, IG3 8XJ|